BHM moved below its 50-day moving average on September 24, 2026 date and that indicates a change from an upward trend to a downward trend. In 33 of 35 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BHM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for BHM entered a downward trend on October 01, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on BHM as a result. In 81 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for BHM just turned positive on October 06, 2026. Looking at past instances where BHM's MACD turned positive, the stock continued to rise in 37 of 41 cases over the following month. The odds of a continued upward trend are 90%.
Following a +1.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where BHM advanced for three days, in 162 of 184 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
FRT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 20 of 37 cases where FRT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 54%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where FRT's RSI Oscillator exited the oversold zone, 14 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 50%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 24 of 64 cases where FRT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 38%.
The Moving Average Convergence Divergence (MACD) for FRT just turned positive on October 12, 2026. Looking at past instances where FRT's MACD turned positive, the stock continued to rise in 23 of 49 cases over the following month. The odds of a continued upward trend are 47%.
Following a +0.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where FRT advanced for three days, in 150 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 49%.
The Momentum Indicator moved below the 0 level on September 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FRT as a result. In 52 of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 52%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FRT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.
The Aroon Indicator for FRT entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 53 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. FRT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.978) is normal, around the industry mean (2.656). P/E Ratio (22.188) is within average values for comparable stocks, (39.045). Projected Growth (PEG Ratio) (3.591) is also within normal values, averaging (12.808). Dividend Yield (0.041) settles around the average of (0.048) among similar stocks. P/S Ratio (7.289) is also within normal values, averaging (6.739).
The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FRT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 65, placing this stock worse than average.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
FRT | ||
|---|---|---|
OUTLOOK RATING 1..100 | 4 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | |
PROFIT vs RISK RATING 1..100 | 83 | |
SMR RATING 1..100 | 59 | |
PRICE GROWTH RATING 1..100 | 58 | |
P/E GROWTH RATING 1..100 | 53 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| BHM | FRT | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 50% |
| Stochastic ODDS (%) | 2 days ago 83% | 2 days ago 38% |
| Momentum ODDS (%) | 2 days ago 90% | 7 days ago 52% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 47% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 47% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 49% |
| Advances ODDS (%) | 9 days ago 88% | 3 days ago 49% |
| Declines ODDS (%) | 2 days ago 90% | 10 days ago 50% |
| BollingerBands ODDS (%) | N/A | 2 days ago 54% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 46% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| INFO | 28.66 | N/A | N/A |
| Harbor PanAgora Dynamic Large Cap Core ETF (INFO) | |||
| QIG | 42.28 | N/A | N/A |
| WisdomTree U.S. Corporate Bond Fund (QIG) | |||
| BSV | 76.37 | -0.02 | -0.03% |
| Vanguard Short-Term Bond ETF (BSV) | |||
| RWLC | 39.52 | -0.06 | -0.16% |
| Rayliant Wilshire Nxtgen US Large Cap Equity ETF | |||
| UVXY | 15.94 | -0.04 | -0.25% |
| ProShares Ultra VIX Short-Term Futures ETF (UVXY) | |||
A.I.dvisor tells us that BHM and IRM have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BHM and IRM's prices will move in lockstep.